These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38174534)

  • 1. Neuroprotective potential of erucic acid via inhibition of N2a cell lines and rotenone induced Parkinson's disease rat model.
    Sharma B; Gupta P; Biswas L; Verma AK; Pasha AM; Thota P; Medhi B
    Indian J Pharmacol; 2023; 55(6):376-384. PubMed ID: 38174534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Supplements of
    Mohammed NA; Abdou HM; Tass MA; Alfwuaires M; Abdel-Moneim AM; Essawy AE
    Curr Pharm Biotechnol; 2020; 21(12):1259-1268. PubMed ID: 32196446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ellagic acid protects dopamine neurons from rotenone-induced neurotoxicity via activation of Nrf2 signalling.
    Wei YZ; Zhu GF; Zheng CQ; Li JJ; Sheng S; Li DD; Wang GQ; Zhang F
    J Cell Mol Med; 2020 Aug; 24(16):9446-9456. PubMed ID: 32657027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
    de Siqueira EA; Magalhães EP; de Assis ALC; Sampaio TL; Lima DB; Marinho MM; Martins AMC; de Andrade GM; de Barros Viana GS
    Neurochem Res; 2023 Jan; 48(1):250-262. PubMed ID: 36066698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of gallic acid and vagotomy on motor function, intestinal transit, brain electrophysiology and oxidative stress alterations in a rat model of Parkinson's disease induced by rotenone.
    Sheikhpour E; Mard SA; Farbood Y; Bavarsad K; Sarkaki A
    Life Sci; 2023 Feb; 315():121356. PubMed ID: 36621537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in SH-SY5Y cells.
    Li L; Chen Z; Hao C
    Brain Res; 2024 May; 1830():148824. PubMed ID: 38417654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
    Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
    J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
    Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease.
    Altinoz MA; Elmaci İ; Hacimuftuoglu A; Ozpinar A; Hacker E; Ozpinar A
    Mol Aspects Med; 2021 Apr; 78():100871. PubMed ID: 32703610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
    Sharma S; Kumar P; Deshmukh R
    Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells.
    Ramkumar M; Rajasankar S; Gobi VV; Dhanalakshmi C; Manivasagam T; Justin Thenmozhi A; Essa MM; Kalandar A; Chidambaram R
    BMC Complement Altern Med; 2017 Apr; 17(1):217. PubMed ID: 28420370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of sterubin against neurochemical and behavioral impairments in rotenone-induced Parkinson's disease.
    Alqurashi MM; Al-Abbasi FA; Afzal M; Alghamdi AM; Zeyadi M; Sheikh RA; Alshehri S; Imam SS; Sayyed N; Kazmi I
    Braz J Med Biol Res; 2024; 57():e12829. PubMed ID: 38359270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
    Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Olajiga AE; Adeyemi OO
    Neurotoxicology; 2023 May; 96():37-52. PubMed ID: 36965781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of p-coumaric acid in mice with rotenone-induced neurodegeneration.
    Dolrahman N; Mukkhaphrom W; Sutirek J; Thong-Asa W
    Metab Brain Dis; 2023 Jan; 38(1):373-382. PubMed ID: 36308586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
    Zhang Q; Chen S; Yu S; Qin J; Zhang J; Cheng Q; Ke K; Ding F
    Neuropharmacology; 2016 Sep; 108():238-51. PubMed ID: 27108097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease.
    Lakkappa N; Krishnamurthy PT; M D P; Hammock BD; Hwang SH
    Neurotoxicology; 2019 Jan; 70():135-145. PubMed ID: 30472438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.
    Sharma S; Raj K; Singh S
    Neurotox Res; 2020 Jan; 37(1):198-209. PubMed ID: 31654381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson's disease.
    Vastegani SM; Khoshnam SE; Mansouri E; Hajipour S; Ghafouri S; Bakhtiari N; Sarkaki A; Farbood Y
    Behav Brain Res; 2023 Feb; 437():114100. PubMed ID: 36075399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
    El-Sayed EK; Ahmed A; Morsy EE; Nofal S
    Hum Exp Toxicol; 2019 Feb; 38(2):173-184. PubMed ID: 30001633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.